Ads
related to: HHS action planlearn.ultimatemedical.edu has been visited by 10K+ users in the past month
Search results
A House committee set out to investigate COVID. Surprisingly, it’s making headway.
The Christian Science Monitor· 6 days agoWhen House Republicans formed a special committee to investigate the COVID-19 pandemic in January...
Trump says he won’t ‘ban’ birth control. Here’s what he may do instead.
Politico· 17 hours agoTaken together, the policies highlight the many ways a second Trump administration could hamper...
Republican Sen. Roger Marshall seeks to block Biden ban on anti-trans discrimination in health care
The Advocate via Yahoo News· 5 days agoThe GOP senator doesn't think a ban on sex discrimination in health care should include gender...
A House committee set out to investigate COVID. Surprisingly, it’s making headway. - CSMonitor.com
The Christian Science Monitor· 7 days agoWhen House Republicans formed a special committee to investigate the COVID-19 pandemic in January 2023, the odds of bipartisan cooperation seemed low. With more than a year’s work under its ...
Republican Sen. Roger Marshall seeks to block Biden ban on anti-trans discrimination in health care
The Advocate· 5 days agoRepublican U.S. Sen. Roger Marshall of Kansas has introduced a bill to block the Biden...
... Care Week in Review: Senate Finance Committee Releases Plan to Address Workforce Shortages,...
JD Supra· 2 days agoBelow is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance;...
FACT SHEET: Biden-Harris Administration Highlights Accomplishments on the Second Anniversary of...
The White House· 5 days agoIn the aftermath of the tragic murder of George Floyd, President Biden signed a historic Executive...
Canadian Drug Importation May Undermine Intellectual Property Protection | JD Supra
JD Supra· 19 hours agoThe Situation: Earlier this year, Florida became the first state to receive authorization for its Section 804 Importation Program ("SIP") from the U.S. Food and Drug Administration ("FDA").
FDA signals potential shift toward interchangeability for all biosimilars | JD Supra
JD Supra· 6 days agoUnder the Biologics Price Competition and Innovation Act (BPCIA), a “biosimilar” product is one that is demonstrated to be “highly similar” to the reference product with “no clinically meaningful ...
